TY - JOUR
T1 - Anatomic distribution of intravenously injected IgG takes approximately 1 week to achieve stratum corneum saturation in vaginal tissues
AU - Carias, Ann M.
AU - Schneider, Jeffrey R.
AU - Madden, Patrick
AU - Lorenzo-Redondo, Ramon
AU - Araınga, Mariluz
AU - Pegu, Amarendra
AU - Cianci, Gianguido C.
AU - Maric, Danijela
AU - Villinger, Francois
AU - Mascola, John R.
AU - Veazey, Ronald S.
AU - Hope, Thomas J.
N1 - Funding Information:
This work was supported by National Institute of Allergy and Infectious Diseases, National Institutes of Health Grants K01OD026571-01 (A.M.C.), K01OD024882-01 (J.R.S.), and HIV Vaccine Research and Design P01AI048240 (T.J.H.) and Center for the Structural Biology of Cellular Host Elements in Egress, Trafficking and Assembly of HIV Grant P50GM082545 (T.J.H.).
Funding Information:
We acknowledge Constadina Arvanitis and David Kirchenbuchler for assistance with lightsheet microscopy. This work was performed at the North-western University Center for Advanced Microscopy, generously supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. We also acknowledge Patrick Kiser for assistance and expertise with fluorescent-labeling methodologies.
Publisher Copyright:
Copyright © 2021 by The American Association of Immunologists, Inc.
PY - 2021/7/15
Y1 - 2021/7/15
N2 - L.v. injected Abs have demonstrated protection against simian HIV infection in rhesus macaques, paving the way for the Antibody Mediated Prevention trial in which at-risk individuals for HIV received an i.v. infusion of the HIV broadly neutralizing Ab VRC01. However, the time needed for these Abs to fully distribute and elicit protection at mucosal sites is still unknown. In this study, we interrogate how long it takes for Abs to achieve peak anatomical levels at the vaginal surface following L.v. injection. Fluorescently labeled VRC01 and/or Gamunex-C were L.v. injected into 24 female rhesus macaques (Macaca mulatta) with vaginal tissues and plasma acquired up to 2 wk postinjection. We found that Ab delivery to the vaginal mucosa occurs in two phases. The first phase involves delivery to the submucosa, occurring within 24 h and persisting beyond 1 wk. The second phase is the delivery through the stratified squamous epithelium, needing ~1 wk to saturate the stratum corneum. This study has important implications for the efficacy of immunoprophylaxis targeting pathogens at the mucosa.
AB - L.v. injected Abs have demonstrated protection against simian HIV infection in rhesus macaques, paving the way for the Antibody Mediated Prevention trial in which at-risk individuals for HIV received an i.v. infusion of the HIV broadly neutralizing Ab VRC01. However, the time needed for these Abs to fully distribute and elicit protection at mucosal sites is still unknown. In this study, we interrogate how long it takes for Abs to achieve peak anatomical levels at the vaginal surface following L.v. injection. Fluorescently labeled VRC01 and/or Gamunex-C were L.v. injected into 24 female rhesus macaques (Macaca mulatta) with vaginal tissues and plasma acquired up to 2 wk postinjection. We found that Ab delivery to the vaginal mucosa occurs in two phases. The first phase involves delivery to the submucosa, occurring within 24 h and persisting beyond 1 wk. The second phase is the delivery through the stratified squamous epithelium, needing ~1 wk to saturate the stratum corneum. This study has important implications for the efficacy of immunoprophylaxis targeting pathogens at the mucosa.
UR - http://www.scopus.com/inward/record.url?scp=85111282309&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111282309&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.2100253
DO - 10.4049/jimmunol.2100253
M3 - Article
C2 - 34162723
AN - SCOPUS:85111282309
SN - 0022-1767
VL - 207
SP - 505
EP - 511
JO - Journal of Immunology
JF - Journal of Immunology
IS - 2
ER -